EROSIVE ESOPHAGITIS
Clinical trials for EROSIVE ESOPHAGITIS explained in plain language.
Never miss a new study
Get alerted when new EROSIVE ESOPHAGITIS trials appear
Sign up with your email to follow new studies for EROSIVE ESOPHAGITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New GERD drug aims to keep esophagus healed, but trial never started
Disease control TerminatedThis study was designed to see if a new drug called linaprazan glurate could keep the esophagus healed in people with GERD-related erosive esophagitis, compared to an existing drug (lansoprazole). Participants would have taken daily pills for up to 52 weeks and had regular camera…
Matched conditions: EROSIVE ESOPHAGITIS
Phase: PHASE3 • Sponsor: Cinclus Pharma Holding AB • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Can nexium keep Kids' esophagitis at bay? new study seeks answers
Disease control OngoingThis phase 3 study tests two doses of Nexium (esomeprazole) in 53 children aged 1 to 11 years who have erosive esophagitis, a condition where stomach acid damages the esophagus. The goal is to see which dose better maintains healing after an initial 8-week treatment period. Child…
Matched conditions: EROSIVE ESOPHAGITIS
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC